Subscriber access provided by UB + Fachbibliothek Chemie | (FU-Bibliothekssystem)
Article
Superior plasticity and tabletability of theophylline monohydrate Shao-Yu Chang, and Changquan Calvin Sun Mol. Pharmaceutics, Just Accepted Manuscript • Publication Date (Web): 26 Apr 2017 Downloaded from http://pubs.acs.org on May 1, 2017
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Molecular Pharmaceutics is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
1
2
Superior plasticity and tabletability of theophylline monohydrate
3
4
Shao-Yu Chang and Changquan Calvin Sun*
5
6
Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of
7
Pharmacy, University of Minnesota, 9-127B Weaver-Densford Hall, 308 Harvard street S.E., Minneapolis,
8
MN 55455
9
10
11
12
*Corresponding author
13
Changquan Calvin Sun, Ph.D.
14
9-127B Weaver-Densford Hall
15
308 Harvard street S.E.
16
Minneapolis, MN 55455
17
Email:
[email protected] 18
Tel: 612-624-3722
19
Fax: 612-626-2125
1 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
20
Page 2 of 27
Abstract
21
A theophylline monohydrate (THm) powder, with particle size and shape substantially similar to
22
a theophylline anhydrate powder, was prepared by vapor mediated phase conversion. The elimination of
23
possible contributions by particle size and shape to tableting properties made it possible to
24
unambiguously identify the role of bonding area and bonding strength on powder tableting performance.
25
It was also shown that accurate true density is essential for correct analysis and understanding of tableting
26
behavior of THm.
27
explained by its unique ladder-like structure, where rigid molecular dimers (rungs) weakly connect to
28
more rigid water chains (rails). The low energy barrier for moving rigid dimers down the rigid water
29
chain enables facile propagation of dislocations in THm crystals when subjected to an external stress.
Experimental evidence revealed surprisingly high plasticity of THm.
This is
30
31
Keyword. Theophylline, plasticity, tabletability, hydrate,
2 ACS Paragon Plus Environment
Page 3 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
32
33
Molecular Pharmaceutics
INTRODUCTION
The establishment of material structure-property relationship is of paramount importance in 1
34
material research in different fields, including pharmaceutical development.
35
structure can more greatly influence the physico-chemical and mechanical properties than the molecular
36
structure. Crystal engineering is, therefore, playing an increasingly important role in materials science
37
research.
38
performance of pharmaceutical powders,
39
compressibility and compactibility.
40
molecular and crystal structure.
41
overcoming powder tableting problems requires a clear understanding of the relationship between crystal
42
structure and mechanical properties. 1, 9
43
2
In fact at times, crystal
Material mechanical properties, e.g., elasticity and plasticity, have been related to tableting
8
5-7
3, 4
which can be systematically analyzed using tabletability,
These mechanical properties, in turn, are influenced by both the
As a result, the development of an effective engineering strategy for
Incorporation of water in crystal lattice often leads to a different crystal structure, which is 10
44
expected to impact pharmaceutically important properties, including mechanical properties.
45
hydrates were found to exhibit better compaction properties than corresponding anhydrates, such as p-
46
hydroxybenzoic acid, where the crystalline water molecules act both as “molecular lubricant” to improve
47
crystal plasticity and “molecular glue” to improve bonding strength. 11 It is of value to explore whether
48
or not such beneficial effects by crystal hydration are of general applicability.
Some
49
Theophylline anhydrate (THa) was shown to be very plastic and exhibited excellent tabletability
50
due to its structural features that lead to multiple slip mechanisms.12 However, theophylline monohydrate
51
(THm) was reported to exhibit even better tableting performance than THa.
52
studies was crystallized from water and, although not mentioned by the authors, likely had a different
53
particle size and shape from those of THa. As such, it remains unclear whether or not the superior
54
tableting performance of THm was due to the different particular properties or differences in mechanical
55
properties.15,
16
13, 14
THm in the previous
Even if the superior tabletability of THm was attributed to the unique mechanical 3 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 4 of 27
56
properties of THm, its structural origin is hitherto unknown, despite the fact that the structure of THm has
57
been known for some time.
58
and THm while minimizing possible contributions from particle size and shape, 2) identify the structural
59
origin of the distinct tableting behavior of THa and THm.
60
MATERIALS AND METHODS
61
Materials
The goals of this study were to 1) compare tableting performance of THa
62
Theophylline anhydrate was obtained from BASF Chemical Co. (Ludwigshafen, Germany).
63
Theophylline monohydrate was prepared by placing theophylline anhydrate in a sealed chamber of 93%
64
relative humidity (RH) over a saturated KNO3 solution. Complete conversion to THm was indicated when
65
sample weight reached a constant value in three consecutive measurements over a period of 15 days.
66
Magnesium stearate was purchased from Tyco Healthcare/Mallinckrodt (Surrey, United Kingdom).
67
Methods
68
Hydration Kinetics
69
As-received THa was dried in an oven at 70 oC for 4 h to remove surface moisture. Accurately
70
weighed, dry THa (~24 g) was evenly placed in three aluminum boats, with surface area of ~40 cm2 and
71
sample thickness of ~6 mm, and stored in a sealed 93% RH chamber.
72
periodically removed from the chamber, weighed, and gently stirred with a spatula before being returned
73
to the chamber for the hydration reaction to continue.
74
Identification of A Suitable RH for Conditioning Powders
The powder sample was
75
In order to reduce the difference in surface moisture before compression, powders were
76
equilibrated at a common RH, at which both THa and THm are kinetically stable. For this purpose, the
4 ACS Paragon Plus Environment
Page 5 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
77
physical stability of THa powder at 75% RH (saturated NaCl solution) and 52% RH (saturated
78
Mg(NO3)2·6H2O solution), and THm powder at 52%, 43% (saturated K2CO3 solution) and 32% RH
79
(saturated MgCl2 solution) were evaluated by monitoring the change of sample weight for at least 50 days.
80
Weight gain of THa samples or weight loss of THm samples indicated unwanted physical instability of
81
corresponding samples.
82
Particle Size Analysis
83
The particle size of THa and THm was determined using a particle size analyzer (Microtrac SIA,
84
Montgomeryville, PA). Approximately ~20 mg of each powder was suspended in IsoparTM G Fluid ( ~5
85
ml) and sonicated for 20 seconds to fully disperse particles. Solubility of theophylline in this medium
86
was negligible. The suspension was added into a sample delivery controller (SDC, Montgomeryville, PA)
87
and circulated. A high speed camera captured image of particles in focus and the area equivalent
88
diameter of each particle was determined using image analysis software. All experiments were triplicated.
89
Powder X-ray Diffractometer (PXRD)
90
The powder X-ray diffraction (PXRD) patterns of THa and THm were obtained using an X-ray
91
diffractometer (Bruker AXS D5005, Madison, WI) with Cu Kα radiation generated at 40 mA and 45 kV.
92
Each powder was placed into a sample holder and pressed by a glass slide to ensure co-planarity between
93
surfaces of the powder and the sample holder. Samples were scanned over the 2θ range of 5˚ - 35˚ in
94
0.04˚ increments with a counting time of 1s at each step. The experimental PXRD patterns of both
95
powders were verified with the theoretical PXRD patterns calculated from crystal structures of THa and
96
THm. 17, 18
97
Thermogravimetric Analysis (TGA)
5 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 6 of 27
98
The water content of THa and THm was determined using a thermogravimetry analyzer (TGA
99
Q50, TA Instruments, New Castle, DE, USA). Powders (2-3 mg) were quickly transferred from a RH
100
chamber to an open aluminum pan and were immediately heated to 300 ˚C at a rate of 10 ˚C/min under
101
dry nitrogen purge at a flow rate of 50 mL/min.
102
Compaction Behavior
103
Aliquots of powder (~200 mg) were loaded into a die and compressed using 8 mm round and flat
104
faced punches on a Zwick Materials Testing Machine (Model 1485; Zwick-Roell, Ulm, Germany) over
105
the compaction pressure range of 25 - 350 MPa at the punch velocity of 2 mm/min without holding at the
106
peak pressure. The punches and die were externally lubricated with a 5% (w/v) suspension of magnesium
107
stearate in ethanol and dried with a fan before each tablet compaction. Three tablets were prepared at
108
each compaction pressure. They were stored in 52% RH overnight to allow relaxation before being
109
further tested.
110
Tablet diameter, D, and thickness, T, were measured using a digital caliper (0.01 mm accuracy),
111
and tablets were weighed using an analytical balance (0.01 mg accuracy). Tablet breaking force, F, was
112
obtained using a texture analyzer (TA-XT2i, Texture Technologies Corp., NY) at a testing speed of 0.01
113
mm/s. Tensile strength, , was calculated according to equation (1). 19
114
=
115
To avoid errors in tablet thickness determination due to flashing, tablets were gently polished on a piece
116
of fine sand paper.
117
True Density Determination
(1)
20
6 ACS Paragon Plus Environment
Page 7 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
118
It is imperative to obtain accurate powder true densities, ρt, in powder compaction research,
119
because even a small error in ρt can have profound impact on the analysis of results of powder tableting
120
data
121
for anhydrous powders, such as THa, but unfit for THm, which undergoes dehydration during
122
measurement.
123
Quantachrome Instruements, Boynton Beach, Florida). For THm powders ρt was obtained by fitting
124
tablet density (ρ) vs. compaction pressure (P) data with equation (2), 22
20, 21
.
The commonly employed helium pycnometry for measuring powder true density is suitable
Therefore, the ρt of THa was measured using helium pycnometry (Ultrapyc 1200e,
125
= 1 − −
126
where the parameter, 1/C, is related to material plasticity. A lower 1/C value corresponds to higher
127
plasticity. The parameter, εc, describes the critical powder porosity at which a continuous 3D network of
128
particle-particle contact is formed. 23 True densities were also calculated from single crystal structures for
129
comparison. The true density values calculated from single crystal structures are expected to be slightly
130
higher than those derived from data fitting because single crystal structures were obtained at sub-ambient
131
temperatures and crystals were assumed to be perfect, while real crystal contain defects. Tablet porosity
132
(ε) was calculated from ρ and ρt according to equation (3).
133
= 1 −
− ln
(2)
(3)
134 135
Hardness Measurement by Macroindentation
136
A spherical stainless indenter (3.18 mm in diameter), attached to a texture analyzer (TA-XT2i,
137
Texture Technologies Corp., NY), was used to indent tablet at the middle of the round tablet face. The
138
indenter traveled downward at a speed of 0.01 mm/min to attain a force (F) that was 60% of the fracture
7 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 8 of 27
139
force of a tablet prepared under the same compaction conditions. The force was maintained for 3 min 24.
140
The indented tablet surface was gently rubbed against a piece of graphite-coated paper to assist the
141
accurate identification of the indent boundary.
142
digital microscope (x200 magnification, Dino-Lite™ Pro AM413MT; AnMo Electronics Corporation,
143
Taiwan). The circular indent was fitted by a three-point method and the projected area, A, was calculated
144
using DinoCapture™ software (V2.0 AnMo Electronics Corporation, Taiwan). Hardness, H, was
145
calculated using equation (4). 25
146
=
147
The hardness - porosity data were fitted using equation (5). 26
148
H = H0 ! "
149
where H0 is the hardness extrapolated to zero porosity and b is an constant. Hardness measurements were
150
triplicated.
24
The area of indents was determined using a calibrated
(4)
(5)
151
152
153
In-die Elastic Recovery
Tablet in-die elastic recovery was calculated from tablet thickness, h0 and h, under peak and zero 28
154
compaction pressure, respectively, using equation (6).
155
ER%= 100(h - h0)/ h0
156
ER reflects the interplay between elastic energy stored in particles during compaction and elastic modulus.
157
A higher ER means a higher extent of elastic recovery upon decompression, which usually leads to more
158
deterioration of tablet strength.
(6)
29
8 ACS Paragon Plus Environment
Page 9 of 27
159
Crystal Structure Analysis
160
The THa (Reference code: BAPLOT) and THm (Reference code: THEOPH01) cifs were
161
downloaded from Cambridge Structural Database and analyzed using Mercury (v3.7, Cambridge
162
Crystallographic Data Centre, Cambridge, UK). Primary slip systems in THa and THm were identified
163
by crystal structure visualization.
164
Results and Discussion
165
The hydration kinetics of as-received THa at 93% RH is shown in Figure 1.
Complete
166
conversion to THm was achieved after ~140 hours (6 days), with the final weight gain of 9.99% exactly
167
matching the theoretical weight gain for 100% conversion.
168
confirmed by PXRD, which agreed with the calculated PXRD and no extraneous peaks could be observed
169
(Figure S1). Particle size distributions of THa and THm were similar (Table 1). No significant change in
170
particle morphology was observed by both optical microscopy (Figure S2) and SEM (Figure S3).
Complete phase conversion was also
11 10 9
Weight change (%)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
8 7 6 5 4 3 2 1 0 0
50
100
150
200
250
300
Time (hrs)
171 172
Figure 1. Conversion kinetics from theophylline anhydrate (THa) to theophylline monohydrate (THm) at
173
93% RH (n = 3). The dashed line indicates expected weight gain for complete conversion. 9 ACS Paragon Plus Environment
Molecular Pharmaceutics
174
175
Table 1. Particle size for theophylline anhydrate (THa) and monohydrate (THm). Standard deviations are
176
in parentheses. THa
THm
D10 [(µm)
21.4 (1.0)
20.2 (0.1)
D50 (µm)
38.2 (1.8)
36.3 (0.6)
D90 (µm)
70.2 (5.4)
65.2 (2.9)
177
b
a
0.3
1 0
THm (52% RH)
Weight change (%)
-1
Weight change (%)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 10 of 27
-2 -3
THm (43% RH)
-4 -5 -6 -7
0.2
THa (75% RH)
0.1
THa (52% RH)
0.0
-8
THm (32% RH)
-9 -0.1
-10 0
10
20
30
40
50
60
0
10
20
30
40
50
60
Time (Days)
Time (Days)
178 179
Figure 2. Phase stability, monitored by weight change, of a) theophylline monohydrate (THm) at 52%,
180
42% and 32% RH, and b) theophylline anhydrate (THa) at 75% and 52% RH.
181
To identify a common RH where both THa and THm are kinetically stable, both materials were
182
stored at various THs at room temperature. At 32% RH, THm underwent rapid weight loss indicating
183
facile dehydration to THa (Figure 2a). At 43% RH, THm dehydrated at a slower rate than at 32% RH,
184
which is consistent with the expectation that faster dehydration occurred at a lower storage RH. At 52%
185
RH, THm was stable for at least 50 days (Figure 2a). THa did not undergo detectable weight change 10 ACS Paragon Plus Environment
Page 11 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
186
when exposed to 52% for 50 day (Figure 2b). However the weight of THa increased by 0.15% at 75% RH
187
after 60 days (Figure 2b), indicating very slow hydration kinetics. As a result, THa and THm were found
188
to be both kinetically stable at 52% RH, even after prolonged storage. This was confirmed by PXRD data,
189
which showed no sign of phase conversion for both THa and THm (Figure 3). Therefore, 52% RH was
190
chosen for storing all powders prior to compaction and all tablets before strength testing throughout this
191
study. For tablets compressed at the highest compaction pressure of 350 MPa, no detectable phase
192
change was evident by XRD data (Figure 3). Thus, a phase change was ruled out as an explanation for
193
the difference in tabletability of THm and THa.
THa (Cal.) THa powder (52% RH) THa tablet (52% RH)
THm (Cal.) THm powder (52% RH) THm tablet (52% RH) 5
10
15
20
25
30
35
2 theta
194 195
Figure 3. X-ray diffraction profiles for powders and tablets of THa and THm, respectively, after storing
196
at 52% RH for 24 h.
197
The TGA thermogram of THa showed about 0.15% weight loss up to 120 ˚C (Figure 4),
198
corresponding to surface moisture.
199
theoretically calculated weight loss (9.08%), indicating dehydration occurred during the brief exposure of
200
the sample to the ambient environment of 15% RH during sample preparation.
However weight loss of THm was 7.88%, which is less than
11 ACS Paragon Plus Environment
Molecular Pharmaceutics
THa
100
Weight change (%)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 12 of 27
95
THm
90 20
40
60
80
100
120
140
160
180
200
Temperature (°C)
201 202
Figure 4. TGA thermograms of theophylline anhydrate (THa) and theophylline monohydrate (THm).
203
Both samples were stored in a 52% RH chamber for a day prior to thermal analysis.
204
205
206
True Density and crystal plasticity
Key crystallographic information of THa and THm from the previously published structures is 17, 18
207
summarized in Table 2.
208
orthorhombic THa to monoclinic THm with an expanded unit cell volume that more than sufficiently
209
compensates additional mass of water, leading to lower true density of THm. True density values of THa
210
and THm from helium pycnometry and fitting compression data are also included for comparison.
The incorporation of water leads to a change in the crystal structure from
211
The true densities of THa and THm obtained from fitting the P-ρ data using equation (1) were
212
1.46 ± 0.02 g/cm3 and 1.43 ± 0.001 g/cm3, respectively (Figure 5). Fitting was excellent for both sets of
213
data as indicated by high coefficients of correlation R2 (> 0.99). The fitted true density of THa is about
214
2% lower than the true density calculated from crystal structure (1.493 g/cm3, Table 2). True density
215
determined by helium pycnometry was 1.49 ± 0.0008 g/cm3, which is nearly identical to that calculated 12 ACS Paragon Plus Environment
Page 13 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
216
from crystal structure (Table 2).
217
measurement, the slightly lower true density form fitting is likely caused by the presence surface moisture
218
(0.75% when equilibrated at 52% before tableting). For THm, the fitted true density is about 3% lower
219
than the calculated density from the crystal structure.
220
crystal structure was solved at a much lower experimental temperature (-100 ˚C); and 2) surface moisture
221
effect similar to that observed in THa. Thus, true density values of THa and THm obtained by fitting
222
were considered sufficiently accurate and used for subsequent calculations of tablet porosity.
223
Table 2. Key crystallographic information for theophylline anhydrate (THa)17 and monohydrate (THm)18.
224
Standard deviations are stated in parentheses.
Since surface moisture is removed during helium pycnometry
18
This value is reasonable considering 1) the
THa Crystal class
Orthorhombic
Monoclinic
Z
4
4
Space group
Pna21
P21/n
a (Å)
24.612 (2)
4.468 (2)
b (Å)
3.8302 (4)
15.355 (5)
c (Å)
8.501 (5)
13.121 (5)
β (˚)
90
97.792 (7)
Volume (Å3)
801.38 (12)
891.9 (6)
Temperature (K)
293
173 (2)
Calculated density (g/cm3)
1.493
1.476
1.49 (0.0008)
1.52 (0.017)
1.46 (0.015)
1.43 (0.001)
Measured density (g/cm3) a Fitted density (g/cm3) b 225 226 227
a. b.
THm
Measured by helium pycnometry at room temperature Obtained by fitting room temperature compression data using equation 2. 13 ACS Paragon Plus Environment
Molecular Pharmaceutics
228
350
Compaction pressure (MPa)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 14 of 27
300 THa
THm
250 200 150 100 50 0 0.9
1.0
1.1
1.2
1.3
1.4
1.5
3
229
Tablet density (g/cm )
230
Figure 5. True density fitting of tablet density – compaction pressure by the Sun equation for
231
theophylline anhydrate (THa) and theophylline monohydrate (THm)
232
The plasticity parameter, 1/C, of THm (166 ± 21 MPa) generated by data fitting is much lower
233
than that of THa (646 ± 181 MPa). This means that, although THa is known to be very plastic, THm is
234
even more plastic than THa. The greater plasticity of plastic THm is expected to allow more permanent
235
deformation under the same stress than the less plastic THa. To solidify this point, we also determined H0
236
of both THm and THa because a material with a lower H0 is more plastic. H of both THa and THm
237
decayed exponentially as predicted by equation (5) (Figure 6, R2 > 0.99 for both). The H0 of THa (217.6
238
± 3.8 MPa) was significantly higher than that of THm (155.5 ± 2.2 MPa). Thus, THm is more plastic
239
than THa by this measure as well.
14 ACS Paragon Plus Environment
Page 15 of 27
300
Hardness (MPa)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
100
THm
THa 10 0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
Porosity
240
241
Figure 6. Hardness of theophylline anhydrate (THa) and theophylline monohydrate (THm).
242
243
244
Compactibility
Tablet tensile strength, σ, usually decreases exponentially with increasing porosity, as described
245
by the Ryshkewitch equation (7). 30
246
σ=σ0 ! "
247
where σ0 is the tensile strength extrapolated to zero porosity and b is an empirical constant. 31 σ0 could be
248
used to quantify bonding strength in this case, because THm and THa possess substantially similar
249
particle size and shape, which would result to the same bonding area at zero porosity.
250
compactibility of both THa and THm obeyed the Ryshkewitch equation (Figure 7, R2 > 0.98 for both).
251
Both the σ0 and b of THa (6.87 ± 0.40 MPa and 10.06 ± 0.3) were higher than that of THm (4.29 ± 0.11
252
MPa, and 4.80 ± 0.24). The lower bonding strength of THm is consistent with its lower true density,
(7)
32
The
15 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 16 of 27
253
similar to some polymorphic systems 33 but different from the p-HBA anhydrate and monohydrate system
254
11
255
bonding area for THm is larger than that of THa because of the higher plasticity of THm, even at the
256
same porosity. Thus, the lower bonding strength of THm is superseded by the positive effect of larger
257
bonding area on σ. With decreasing porosity, the σ of THa increased faster than THm. Consequently, the
258
two compactibility curves cross approximately at porosity of 0.09, below which σ of THa is higher than
259
that of THm. At low porosities, the difference in the actual bonding area is minimal, and the higher
260
bonding strength of THa dominates the bonding area-bonding strength interplay. This is different from
261
the earlier work that suggested THm exhibited higher σ at the entire porosity range, and σ0 of THm is
262
higher than that of THa. 13 This contradiction may have been caused by using a poor estimate of the true
263
density in the calculation of the tablet porosity of THm in the earlier work. Although not specified by
264
those authors, the true density of THm was likely measured using helium pycnometry, the prevailing
265
method at that time. If so, the measured true density would be higher due to dehydration of THm during
266
the course of measurement.
267
helium pycnometry (1.52 g/cm3), the compactibility curve of THm shifted to the right hand side to the
268
extent that it no longer intersects compactibility curve of THa (Figure S4), which is the same as that
269
reported in the literature. 13
.
At porosities greater than 0.1, σ of THm is higher than THa. This is attributed to the fact that the
22
In fact, when using the higher value of the true density measured by
16 ACS Paragon Plus Environment
Page 17 of 27
10
Tensile strength (MPa)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
THm 1
THa
0.1 0.00
0.05
0.10
0.15
0.20
0.25
Porosity
270 271
Figure 7. Compactibility of theophylline anhydrate (THa) and theophylline monohydrate (THm).
272
Compressibility
273
Compressibility is reflected in the plot of tablet porosity as a function of compaction pressure.
274
Other things being equal and under identical compaction condition, a more compressible material forms
275
tablets with lower porosity. When a powder is compressed, it undergoes volume reduction through
276
particle rearrangement, fragmentation of particles, and plastic deformation.34 The porosity of both THa
277
and THm tablets decreased with the increasing compaction pressure as expected (Figure 8). At 25 MPa,
278
tablet porosity of THa and THm was nearly identical, which is consistent with the expected similar
279
powder packing for two powders with essentially the same particle size and shape. However, tablet
280
porosity diverged with increasing pressure. The porosity of THm tablets was significantly lower than that
281
of THa at pressure ≥ 50 MPa. The faster elimination of pores in THm tablets is in keeping with the
282
higher plasticity of THm. Lower porosity means larger bonding area in a THm tablet than in a THa tablet
283
at a given compaction pressure, which favors higher tablet strength.
17 ACS Paragon Plus Environment
Molecular Pharmaceutics
0.25
0.20
Porosity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 18 of 27
0.15
0.10 THa 0.05 THm 0.00 0
50
100
150
200
250
300
350
Compaction pressure (MPa)
284 285
Figure 8. Compressibility of theophylline anhydrate (THa) and theophylline monohydrate (THm).
286
Tabletability
287
Tablet tensile strength of both THa and THm increased with increasing compaction pressure
288
(Figure 9).
289
deformation of particles, which leads to larger bonding area between adjacent particles. The tabletability
290
profiles of THa and THm converge with increasing compaction pressure. At 25 and 50 MPa, the tensile
291
strength of THm tablets was nearly two fold that of THa. At the compaction pressure ~300 MPa, tensile
292
strength of THa and THm tablets became essentially the same. This observation is consistent with the
293
observation that THa have stronger bonding strength (Figure 7), which gradually dominates the bonding
294
area – bonding strength (BABS) interplay when difference in bonding area diminishes at higher pressures.
295
The excellent tabletability of THa obtained in this work is in agreement with the previous report. 12 It is
296
attributed to its high plasticity resulting from the presence of multiple slip mechanisms in the crystal.
297
Surprisingly, the presence of water in the crystal structure even further improves tableting performance.
This is expected because higher compaction pressure causes more permanent plastic
18 ACS Paragon Plus Environment
Page 19 of 27
35
298
According to the BABS interplay model,
299
higher tabletability of THm due to its higher plasticity.
the larger bonding at lower pressures is responsible for the
6
5
Tensile strength (MPa)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
4
THm 3
2
1
THa 0 0
300 301
50
100
150
200
250
300
350
400
Compaction pressure (MPa)
Figure 9. Tabletability of theophylline anhydrate (THa) and theophylline monohydrate (THm).
302
An understanding of the impact of interparticular bonding area on different tabletability of THa
303
and THm requires consideration of the tablet tensile strength normalized by tablet porosity, i.e.,
304
compactibility analysis (Figure 7), and tablet porosity as a function of compaction pressure, i.e.,
305
compressibility analysis (Figure 8). As discussed above, THm exhibits lower bonding strength but larger
306
bonding area when compressed at the same compaction pressure. At low pressures, the larger bonding
307
area (due to higher plasticity) in THm tablets dominates the BABS interplay. Therefore, tablet tensile
308
strength is higher for THm. At high pressures, the dominance of bonding area is less prominent because
309
both approach zero porosity. As a result, the bonding strength plays a more important role, which is
310
reflected as the convergence of tensile strength at pressures higher than 300 MPa (Figure 9).
311
19 ACS Paragon Plus Environment
Molecular Pharmaceutics
312
In-die elastic recovery
313
Elastic recovery during decompression tends to reduce bonding area developed during
314
compression. For both THa and THm, in-die elastic recovery increased with increasing compaction
315
pressure (Figure 10). A higher compaction pressure induces more extensive plastic deformation between
316
particles, but it also leads to more stored elastic energy in particles. As a result, higher elastic recovery is
317
observed. At all compaction pressures, THa underwent higher degree of in-die elastic recovery than THm.
318
This contributes to higher porosity and weaker THa tablets at the same compaction pressures, despite of
319
the higher bonding strength of THa (Figure 7). 36
THa
5
In-die elastic recovery (%)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 20 of 27
4
3
THm 2
1
0 0
50
100
150
200
250
300
350
400
Compaction pressure (MPa)
320 321
Figure 10. In-die elastic recovery of theophylline anhydrate (THa) and theophylline anhydrate (THm)
322
tablets as a function of compaction pressure.
323
Crystal Structural origin of superior plasticity of THm
324 325
To explain the high plasticity of THm, it is useful to compare the crystal structures of THa and THm for structural insight, especially slip mechanism responsible for plastic deformation.
Slip planes 20
ACS Paragon Plus Environment
Page 21 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
37
326
can be identified by either visual inspection of crystal packing or attachment energy calculation.
327
planes typically have the lowest attachment energy, which is defined as the energy released in attaching a
328
new layer of molecules to a growing crystal face. It was previously shown that theophylline molecules in
329
THa form V-shaped hydrogen-bonded rigid columns, which stack to form flat layers. 12 When subject to
330
stress, columns are able to slide more easily than the classical stacking flat sheets structure of plastic
331
crystals.
332
external stress induced slip in the crystal less directionally dependent. Slip of the stacking layers is also
333
possible to accommodate plastic deformation.
334
deformation, which contributes to its excellent tabletability. 12
38-40
Slip
Additionally, columns in adjacent layers in THa lie at the angle of 111.61˚, which makes
Thus, THa responds to stress through facile plastic
a
b
c
c
b
b a
a Layer 1
Layer 2
Layer 1
Layer 2
2.900 2.744 2.726
2.763 3.205
335 336
Figure 11. Crystal structure of theophylline monohydrate a) along a axis, layers 1 and 2 are indicated by
337
red and blue planes, respectively; b) rotating 48.2˚ along b axis in the direction of dotted arrow.
338
Molecules are shown in red and blue colors for layer 1 and 2, respectively
21 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
339
Page 22 of 27
The better tabletability of THm than THa (Figure 8), despite its lower bonding strength (Figure 6), 35
340
suggests larger bonding area in THm tablets dominates the bonding area-bonding strength interplay.
341
Therefore, THm must exhibit even greater plasticity than THa. This requires a more effective plastic
342
deformation mechanism of the THm crystal.
343
molecule into the THm crystal lattice leads to approximately 11% expansion in unit cell volume (Table 2).
344
This process can potentially introduce additional defects to the crystal lattice. However, the THa powder
345
consisted of polycrystalline particles, likely because it was manufactured through dehydrating
346
monohydrate crystals. Thus, the potentially higher defect concentration in THm cannot fully explain its
347
significantly higher plasticity than THa. An inspection of the THm crystal structure revealed that water
348
molecules are bonded through O-H···O hydrogen bonds to form water chains running in the
349
direction (Figure 11). Theophylline dimers, with an inversion center and fortified through two N-H···O
350
hydrogen-bonds, connect to water molecules in two parallel water chains on either side through N-H···O
351
hydrogen-bonds (Figure 11a). Such dimers stack along adjacent water chains to form a ladder like
352
structure.
353
layer but shifted to the side by half of the width of the ladder. Dimers in adjacent layers lie at an angle of
354
158.81˚ (Figure 11b).
355
molecule in the adjacent layers through a C-H···O hydrogen bond. Since these layers are not flat, facile
356
slide between layers is unlikely. Therefore, this type of structures is expected to lead to low plasticity and,
357
hence, poor tableting performance if these layers are rigid.
358
high plasticity, shown by its lower H0 and 1/C than THa, this structure must allow facile propagation of
359
dislocations through a mechanism not recognized before.
During the hydration process, the incorporation of water
Lateral repetition of such ladders forms a layer. Adjacent layers are mirror images of this
Each theophylline molecule in a dimer connects with another theophylline
41-43
Since THm actually exhibits excellent
360
Because hydrogen bonds between dimer and water is weak (N-O distance is 2.900 Å) compared
361
to hydrogen bonds between the dimers (N-O distance is 2.763 Å) or between adjacent water molecules
362
within the water chain (O-O distance is 2.744 and 2.726 Å), water chains and the dimers serve as sturdy
363
rail and rungs, respectively. The C-H···O hydrogen bonds (C-O distance of 3.205 Å) between dimers in 22 ACS Paragon Plus Environment
Page 23 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
364
neighboring layers are the weakest among all hydrogen bonds. Thus, when subjected to an external stress,
365
the rigid ladders can be displaced along the direction from their position at rest with little
366
resistance since only the weak N-H···O hydrogen bonds are necessary to be overcome for plastic
367
deformation. More importantly, the displacement of the dimeric rungs will propagate through the rigid
368
pillars easily because only a few dimers are involved for a dislocation to move along the water chains in
369
the THm crystal (Figure 12a-c). Hence, plastic deformation can take place under a stress much lower
370
than that required to simultaneously move the entire column as in THa.
371
a
b
F
F
c
F
372 373
Figure 12. Illustration of crystal deformation of theophylline monohydrate (THm): a) Initial state when
374
subject to stress; b) When the hydrogen bonds (blue dotted line) of theophylline dimers were overcome,
375
the dimers were consecutively displaced and moved forwards along water chains; c) Theophylline dimer
376
moved to the other end of the crystal at the end of the deformation process.
377
Conclusion
23 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 24 of 27
378
The use of theophylline anhydrate and monohydrate with nearly identical particle size and shape
379
allowed identification of the role of bonding area and bonding strength on powder tableting performance.
380
Accurate true density is essential for correct analysis and understanding of tableting behavior of THm.
381
THm displayed surprisingly high plasticity and superior tabletability, which is explained by its unique
382
structure, consisting of rigid molecular rungs weakly connecting to rigid rails of water chains. Such
383
unique structure enables facile propagation of dislocations with minimum resistance when subjected to an
384
external stress.
385
simulation, will facilitate its application in crystal engineering to solve challenges related to mechanical
386
properties of organic crystals.
Better understanding of this mechanism of plastic deformation, e.g., by computer
387
388
Supporting Information
389
The Supporting Information is available free of charge on the ACS Publications website.
390
Powder X-ray diffractograms, polarized light microscopic images, scanning electron microscopic images,
391
effects of erroneous true density on compactibility of THm and THa.
392
393
Acknowledgements
394
Portions of this work were carried out in the Characterization Facility, University of Minnesota, which
395
receives partial support from NSF through the MRSEC program, and the Minnesota Nano Center, which
396
receives partial support from the NSF through the NNCI program.
397
398
References 24 ACS Paragon Plus Environment
Page 25 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445
Molecular Pharmaceutics
1. Sun, C. C. Materials Science Tetrahedron—A Useful Tool for Pharmaceutical Research and Development. J. Pharm. Sci. 2009, 98, (5), 1671-1687. 2. Desiraju, G. R. Crystal engineering: from molecule to crystal. Journal of the American Chemical Society 2013, 135, (27), 9952-9967. 3. Hiestand, E. N. Mechanical Properties of Compacts and Particles that Control Tableting Success. J. Pharm. Sci. 1997, 86, (9), 985-990. 4. Jain, S. Mechanical properties of powders for compaction and tableting: an overview. Pharm. Sci. Technolo. Today 1999, 2, (1), 20-31. 5. Joiris, E.; Martino, P.; Berneron, C.; Guyot-Hermann, A.-M.; Guyot, J.-C. Compression Behavior of Orthorhombic Paracetamol. Pharm Res 1998, 15, (7), 1122-1130. 6. Tye, C. K.; Sun, C.; Amidon, G. E. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J. Pharm. Sci. 94, (3), 465-472. 7. Patel, S.; Kaushal, A. M.; Bansal, A. K. Compression physics in the formulation development of tablets. Critical Reviews™ in Therapeutic Drug Carrier Systems 2006, 23, (1). 8. Bag, P. P.; Chen, M.; Sun, C. C.; Reddy, C. M. Direct correlation among crystal structure, mechanical behaviour and tabletability in a trimorphic molecular compound. CrystEngComm 2012, 14, (11), 3865-3867. 9. Reddy, C. M.; Rama Krishna, G.; Ghosh, S. Mechanical properties of molecular crystalsapplications to crystal engineering. CrystEngComm 2010, 12, (8), 2296-2314. 10. Khankari, R. K.; Grant, D. J. Pharmaceutical hydrates. Thermochimica Acta 1995, 248, 61-79. 11. Sun, C. C.; Grant, D. J. Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight. Pharm. Res. 2004, 21, (2), 382-386. 12. Chattoraj, S.; Shi, L.; Sun, C. C. Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1: 1 co-crystal. CrystEngComm 2010, 12, (8), 2466-2472. 13. Agbada, C.; York, P. Theophylline hydrate/anhydrous system: effects of water of hydration on mechanical properties of compacted beams. J. Pharm. Pharmacol. 1990, 42, (S1), 76P-76P. 14. Suihko, E.; Lehto, V.-P.; Ketolainen, J.; Laine, E.; Paronen, P. Dynamic solid-state and tableting properties of four theophylline forms. Int. J. Pharm. 2001, 217, (1), 225-236. 15. Khomane, K. S.; Bansal, A. K. Effect of particle size on in-die and out-of-die compaction behavior of ranitidine hydrochloride polymorphs. AAPS PharmSciTech 2013, 14, (3), 1169-1177. 16. Garekani, H. A.; Ford, J. L.; Rubinstein, M. H.; Rajabi-Siahboomi, A. R. Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol. Int. J. Pharm. 1999, 187, (1), 77-89. 17. Ebisuzaki, Y.; Boyle, P. D.; Smith, J. A. Methylxanthines. I. Anhydrous theophylline. Acta Crystallographica Section C: Crystal Structure Communications 1997, 53, (6), 777-779. 18. Sun, C.; Zhou, D.; Grant, D. J.; Young Jr, V. G. Theophylline monohydrate. Acta Crystallographica Section E: Structure Reports Online 2002, 58, (4), 0368-0370. 19. Fell, J. T.; Newton, J. M. Determination of tablet strength by the diametral-compression test. Journal of Pharmaceutical Sciences 1970, 59, (5), 688-691. 20. Paul, S.; Chang, S.-Y.; Sun, C. C. The phenomenon of tablet flashing—its impact on tableting data analysis and a method to eliminate it. Powder. Technol. 2017, 305, 117-124. 21. Sun, C. C. Quantifying errors in tableting data analysis using the Ryshkewitch equation due to inaccurate true density. J. Pharm. Sci. 2005, 94, (9), 2061-2068. 22. Sun, C. C. A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders. J. Pharm. Sci. 2004, 93, (3), 646-653.
25 ACS Paragon Plus Environment
Molecular Pharmaceutics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490
Page 26 of 27
23. Sun, C. C. Microstructure of tablet—pharmaceutical significance, assessment, and engineering. Pharm. Res. 2016, 1-11. 24. Patel, S.; Sun, C. C. Macroindentation hardness measurement—modernization and applications. Int. J. Pharm. 2016, 506, (1), 262-267. 25. Tabor, D., The Hardness of Metals, Clarendon. Oxford: 1951. 26. Soroka, I.; Sereda, P. J. Interrelation of hardness, modulus of elasticity, and porosity in various gypsum systems. Journal of the American Ceramic Society 1968, 51, (6), 337-340. 27. Holman, L.; Leuenberger, H. The relationship between solid fraction and mechanical properties of compacts—the percolation theory model approach. Int. J. Pharm. 1988, 46, (1-2), 35-44. 28. Sun, C. C.; Grant, D. J. W. Influence of elastic deformation of particles on Heckel analysis. Pharm. Dev. Technol. 2001, 6, (2), 193-200. 29. Sun, C. C.; Hou, H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Crystal Growth and Design 2008, 8, (5), 1575-1579. 30. Ryshkewitch, E. Compression strength of porous sintered alumina and zirconia. Journal of the American Ceramic Society 1953, 36, (2), 65-68. 31. Roberts, R. J.; Rowe, R. C.; York, P. The relationship between the fracture properties, tensile strength and critical stress intensity factor of organic solids and their molecular structure. Int. J. Pharm. 1995, 125, (1), 157-162. 32. Sun, C. C. Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose. Int. J. Pharm. 2008, 346, (1–2), 93-101. 33. Upadhyay, P.; Khomane, K. S.; Kumar, L.; Bansal, A. K. Relationship between crystal structure and mechanical properties of ranitidine hydrochloride polymorphs. CrystEngComm 2013, 15, (19), 39593964. 34. Wray, P. E. The physics of tablet compaction revisited. Drug. Dev. Ind. Pharm. 1992, 18, (6-7), 627-658. 35. Osei-Yeboah, F.; Chang, S.-Y.; Sun, C. C. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting. Pharm. Res. 2016, 33, (5), 1126-1132. 36. Rowe, R. C.; Roberts, R. J. Pharmaceutical Powder Compaction Technology. Marcel Dekker, New York 1996. 37. Sun, C. C.; Kiang, Y. H. On the identification of slip planes in organic crystals based on attachment energy calculation. Journal of Pharmaceutical Sciences 2008, 97, (8), 3456-3461. 38. Chattoraj, S.; Shi, L.; Chen, M.; Alhalaweh, A.; Velaga, S.; Sun, C. C. Origin of deteriorated crystal plasticity and compaction properties of a 1: 1 cocrystal between piroxicam and saccharin. Crystal Growth & Design 2014, 14, (8), 3864-3874. 39. Reddy, C. M.; Padmanabhan, K. A.; Desiraju, G. R. Structure− property correlaJons in bending and brittle organic crystals. Crystal growth & design 2006, 6, (12), 2720-2731. 40. Krishna, G. R.; Devarapalli, R.; Lal, G.; Reddy, C. M. Mechanically Flexible Organic Crystals Achieved by Introducing Weak Interactions in Structure: Supramolecular Shape Synthons. Journal of the American Chemical Society 2016, 138, (41), 13561-13567. 41. Sun, C.; Grant, D. W. Influence of Crystal Structure on the Tableting Properties of Sulfamerazine Polymorphs. Pharm. Res. 2001, 18, (3), 274-280. 42. Ahmed, H.; Shimpi, M. R.; Velaga, S. P. Relationship between mechanical properties and crystal structure in cocrystals and salt of paracetamol. Drug. Dev. Ind. Pharm. 2016, 1-9. 43. Khomane, K. S.; Bansal, A. K. Weak hydrogen bonding interactions influence slip system activity and compaction behavior of pharmaceutical powders. J. Pharm. Sci. 2013, 102, (12), 4242-4245.
491
26 ACS Paragon Plus Environment
Page 27 of 27 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Molecular Pharmaceutics
Table of Contents Graphic: Title: Superior plasticity and tabletability of theophylline monohydrate
Authors: Shao-Yu Chang and Changquan Calvin Sun*
ACS Paragon Plus Environment